As per this study the Global Scopolamine Market was valued USD XX MN (by revenue) in 2019 and is anticipated to reach USD XX MN by 2026 with a CAGR of XX%.
Scopolamine or hyoscine is the alkaloid drug prescribed to treat postoperative nausea and vomiting and prevent motion sickness. It is anticholinergics that target CNS to create calming effect on gut and stomach muscles. It can be introduced into patients body through mouth, subcutaneously, opthalmically, intravenously and by transdermal patch. It is also used to dry up salivary secretions and dilate bronchi and pupil in case of any medical procedures.
An increasing number of domestic and international travelers undergoing motion sickness is driving the market growth. Use of scopolamine to treat stomach problem, muscle spams and Parkinson like medical conditions is further boosting the market growth. Also, growing nmber of surgeries leading into rise in demand of product to control postoperative nausea and hyper salivary secretion is again pushing the market growth uphill. However, stringent regulation on production in various regions is likely to hinder the market growth.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of scopolamine.
The broad scopolamine market has been sub-grouped into dosage form and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Dosage Form
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for scopolamine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Scopolamine Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the scopolamine market include Alchem International, Alkaloids of Australia, Baxter International Inc., Caleb Pharmaceuticals, Inc., Centroflora-Cms, Fine Chemicals Corporation, GlaxoSmithKline plc., Myungmoon Pharma Co. LTD., Novartis AG, Perrigo Company plc. and Phytex Australia. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.